Romosozumab in Postmenopausal Korean Women with Osteoporosis: A Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study

Ki-Hyun Baek; Yoon-Sok Chung; Jung-Min Koh; In Joo Kim; Kyoung Min Kim; Yong-Ki Min; Ki Deok Park; Rajani Dinavahi; Judy Maddox; Wenjing Yang; Sooa Kim; Sang Jin Lee; Hyungjin Cho; Sung-Kil Lim

doi:10.3803/enm.2020.848

Romosozumab in Postmenopausal Korean Women with Osteoporosis: A Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study

Endocrinology and Metabolism ◽

10.3803/enm.2020.848 ◽

2021 ◽

Vol 36 (1) ◽

pp. 60-69

Author(s):

Ki-Hyun Baek ◽

Yoon-Sok Chung ◽

Jung-Min Koh ◽

In Joo Kim ◽

Kyoung Min Kim ◽

...

Keyword(s):

Korean Women ◽

Efficacy And Safety ◽

Safety Study ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Clinical Trial Protocol: Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy, and Safety Study Comparing EG-1962 to Standard of Care Oral Nimodipine in Adults with Aneurysmal Subarachnoid Hemorrhage [NEWTON-2 (Nimodipine Microparticles to Enhance Recovery While Reducing TOxicity After SubarachNoid Hemorrhage)]

Neurocritical Care ◽

10.1007/s12028-018-0575-z ◽

2018 ◽

Vol 30 (1) ◽

pp. 88-97 ◽

Cited By ~ 17

Author(s):

Daniel Hänggi ◽

◽

Nima Etminan ◽

Stephan A. Mayer ◽

E. Francois Aldrich ◽

...

Keyword(s):

Subarachnoid Hemorrhage ◽

Aneurysmal Subarachnoid Hemorrhage ◽

Standard Of Care ◽

Efficacy And Safety ◽

Safety Study ◽

Phase 3 ◽

Double Blind ◽

Group Efficacy ◽

Double Blind Placebo ◽

Parallel Group

Download Full-text

The efficacy and safety study of dietary supplement PURIAM110 on non-insulin taking Korean adults in the stage of pre-diabetes and diabetes mellitus: protocol for a randomized, double-blind, placebo-controlled, and multicenter trial-pilot study

Trials ◽

10.1186/1745-6215-12-38 ◽

2011 ◽

Vol 12 (1) ◽

Cited By ~ 2

Author(s):

Sunju Park ◽

Jeong-Su Park ◽

Hoyeon Go ◽

Bo-Hyoung Jang ◽

Yongcheol Shin ◽

...

Keyword(s):

Diabetes Mellitus ◽

Pilot Study ◽

Dietary Supplement ◽

Multicenter Trial ◽

Efficacy And Safety ◽

Safety Study ◽

Double Blind ◽

Double Blind Placebo ◽

Korean Adults

Download Full-text

The combination of olmesartan medoxomil and amlodipine besylate in controlling high blood pressure: COACH, a randomized, double-blind, placebo-controlled, 8-week factorial efficacy and safety study

Clinical Therapeutics ◽

10.1016/j.clinthera.2008.04.002 ◽

2008 ◽

Vol 30 (4) ◽

pp. 587-604 ◽

Cited By ~ 193

Author(s):

Steven G. Chrysant ◽

Michael Melino ◽

Sulekha Karki ◽

James Lee ◽

Reinilde Heyrman

Keyword(s):

Blood Pressure ◽

High Blood Pressure ◽

Olmesartan Medoxomil ◽

Efficacy And Safety ◽

Amlodipine Besylate ◽

Safety Study ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Asian sildenafil efficacy and safety study (ASSESS-1): a double-blind, placebo-controlled, flexible-dose study of oral sildenafil in Malaysian, Singaporean, and Filipino men with erectile dysfunction

Urology ◽

10.1016/s0090-4295(00)00688-9 ◽

2000 ◽

Vol 56 (4) ◽

pp. 635-640 ◽

Cited By ~ 41

Author(s):

Hui Meng Tan ◽

Clarence Lei Chang Moh ◽

Jesus Benjamin Mendoza ◽

Telesforo Gana ◽

German Jose Albano ◽

...

Keyword(s):

Erectile Dysfunction ◽

Efficacy And Safety ◽

Safety Study ◽

Double Blind ◽

Double Blind Placebo ◽

Dose Study ◽

Flexible Dose

Download Full-text

A randomized, double-blind, placebo-controlled, efficacy and safety study of acetaminophen 1000 mg and acetaminophen 650 mg in postoperative dental pain

Journal of Pain ◽

10.1016/j.jpain.2012.01.306 ◽

2012 ◽

Vol 13 (4) ◽

pp. S74 ◽

Cited By ~ 2

Author(s):

D. Qi ◽

L. May ◽

B. Zimmerman ◽

P. Peng ◽

E. Atillasoy ◽

...

Keyword(s):

Dental Pain ◽

Efficacy And Safety ◽

Safety Study ◽

Double Blind ◽

Double Blind Placebo ◽

Postoperative Dental Pain

Download Full-text

Comparison of acetaminophen 1000 mg and acetaminophen 650 mg in an acute pain model: results from a randomized, double-blind, placebo-controlled, efficacy and safety study

Osteoarthritis and Cartilage ◽

10.1016/j.joca.2012.02.267 ◽

2012 ◽

Vol 20 ◽

pp. S175

Author(s):

D.S. Qi ◽

L.G. May ◽

B.A. Zimmerman ◽

P.Y. Peng ◽

E.O. Atillasoy ◽

...

Keyword(s):

Acute Pain ◽

Efficacy And Safety ◽

Safety Study ◽

Double Blind ◽

Pain Model ◽

Double Blind Placebo

Download Full-text

A Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Quetiapine or Lithium as Monotherapy for Mania in Bipolar Disorder

The Journal of Clinical Psychiatry ◽

10.4088/jcp.v66n0116 ◽

2005 ◽

Vol 66 (01) ◽

pp. 111-121 ◽

Cited By ~ 242

Author(s):

Charles L. Bowden ◽

Heinz Grunze ◽

Jamie Mullen ◽

Martin Brecher ◽

Björn Paulsson ◽

...

Keyword(s):

Bipolar Disorder ◽

Efficacy And Safety ◽

Safety Study ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

A Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Quetiapine or Lithium as Monotherapy for Mania in Bipolar Disorder

Yearbook of Psychiatry and Applied Mental Health ◽

10.1016/s0084-3970(08)70202-0 ◽

2006 ◽

Vol 2006 ◽

pp. 207

Author(s):

J.C. Ballenger

Keyword(s):

Bipolar Disorder ◽

Efficacy And Safety ◽

Safety Study ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

1082 – 40-week, randomized, double-blind, placebo-controlled, multicenter, efficacy and safety study of methylphenidate hydrochloride modified release (MPH-LA) in adults with attention deficit hyperactivity disorder (ADHD)

European Psychiatry ◽

10.1016/s0924-9338(13)76193-5 ◽

2013 ◽

Vol 28 ◽

pp. 1

Author(s):

M. Huss ◽

Y. Ginsberg ◽

A. Philipsen ◽

T. Tvedten ◽

T. Arngrim ◽

...

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Attention Deficit ◽

Modified Release ◽

Efficacy And Safety ◽

Safety Study ◽

Double Blind ◽

Double Blind Placebo ◽

Hyperactivity Disorder

Download Full-text

J06 A randomized, double-blind, placebo-controlled phase ii efficacy and safety study of the PDE10A inhibitor PF-02545920 in huntington disease (amaryllis)

10.1136/jnnp-2018-ehdn.266 ◽

2018 ◽

Author(s):

Marielle Delnomdedieu ◽

Ye Tan ◽

Adam Ogden ◽

Zdenek Berger ◽

Ralf Reilmann

Keyword(s):

Phase Ii ◽

Huntington Disease ◽

Efficacy And Safety ◽

Safety Study ◽

Double Blind ◽

Double Blind Placebo

Download Full-text